Matrixyl 3000 dosage: what sources say
| Source | Strength | Schedule | People | Length |
|---|---|---|---|---|
| Maker's newer sheet, 20151 | 3% cream on half the face, against placebo | Twice daily | 23 women aged 42 to 67 | 2 months |
| Maker's older sheet, 20072 | 4% cream on half the face, placebo on the other half | Twice a day | 39 men aged 54.5 ± 6 years | 56 days |
Strengths and schedules in the sources
The table is set at the top of the page
Matrixyl 3000 is sold to formulators as a water-soluble ingredient, not as a vial or a dose.1 The maker's newer sheet gives a recommended use level of 3% in a finished product, and its older sheet gives 3 - 4%.12 All three of the maker's studies put the cream on one half of the face against placebo, and the 28-woman study also covered the forearm.12 In the newer sheet's 23-woman study, the surface occupied by deep wrinkles fell 39.4% from the start on the Matrixyl 3000 side after 2 months, against a change on placebo that the sheet marks as not significant, and main wrinkle density changed by 32.9 against a placebo change also marked not significant.1 Separately, the Cosmetic Ingredient Review panel reports typical use concentrations below 10 ppm for these peptides in cosmetics, a figure for the peptides themselves rather than for the Matrixyl 3000 ingredient.3
How often it is applied, and what trials reported
A DailyMed label for Derma Under Eye gel, which holds both peptides with hyaluronic acid, says to pat the gel around the eyes after cleansing and to use it morning and evening on dark circles.4 A search of the maker's two sheets, PubMed and DailyMed found no cycle, break or on/off period. The 2024 eye-cream trial by Yang and colleagues tested a cream with both peptides and other actives and followed people to 12 weeks; in their limitations, the authors note a small sample and say the study did not include a control or placebo group.5
Mixing, route and storage
No mixing or reconstitution instructions turned up in the maker's two sheets, DailyMed or PubMed, and the maker's sheet describes Matrixyl 3000 as water soluble.1 The under-eye gel label is for external use only and gives a 15 g tube.4 No injectable product, label or trial turned up, so there is no mg/mL figure to work a U-100 syringe from (units and dosing). That gel label says to store below 30 °C.4 The maker's sheets give no storage conditions for the ingredient itself.
Frequently asked questions
What is Matrixyl 3000?
The maker's sheet defines it as an association of two palmitoylated matrikines (peptides), covered on the Matrixyl 3000 page and in cosmetic and copper peptides.1
Is there a label for Matrixyl 3000?
A DailyMed search found no label for "matrixyl" and eight cosmetic or OTC-listed labels for "palmitoyl tripeptide".
What safety information do sources give?
The Cosmetic Ingredient Review panel's 2018 safety assessment, which covers palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 among other peptides, concluded that these ingredients are safe in cosmetics in the present practices of use and concentration described in that assessment.3 In the 2024 eye-cream trial, whose cream held both peptides with other actives, dermatologists observed no adverse reactions such as skin papules, erythema, scabbing or desquamation over the study period.5 The Derma Under Eye gel label also says to avoid contact with eyes and mucous membranes and lists hypersensitivity to any of the components as a contraindication.4
References
- Sederma (technical data sheet). untitled. cdn.shopify.com
- Sederma (older technical data sheet). Matrixyl3000-Men_USA.indd. alfaspa.ua
- Int J Toxicol (CIR). Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics. pure.psu.edu
- Pella Pharmaceuticals Co. Ltd via DailyMed (US label). Under Eye. 2021. dailymed.nlm.nih.gov
- Journal article. Comprehensive evaluation of the efficacy and safety of a new multi‐component anti‐aging topical eye cream. 2024. pmc.ncbi.nlm.nih.gov